期刊文献+

适形放疗晚期肺癌放射性食管炎相关因素分析 被引量:4

Analysis of factors predicting radiation esophagitis in the treatment of advanced lung cancer with three-dimensional conformal radiotherapy
原文传递
导出
摘要 目的分析Ⅲ~Ⅳ期非小细胞肺癌三维适形放射治疗中急性放射性食管损伤(AE)的发生率及其相关因素。方法选择2006年3月至2008年11月行三维适形放疗的晚期肺癌患者195例,男165例,女30例。其中79例患者行同步放化疗,中位等效生物剂量为72.0 Gy,观察AE的发生率,采用单因素和多因素变量分析方法,对选择的临床和剂量学因素进行与2级以上AE的相关性分析。结果 2级AE 38例(19.5%),3级AE 25例(12.8%)。单变量分析显示,临床因素中疗前体重下降≥5%、同时化放疗、淋巴结分期、临床类型和后程超分割放疗与2级以上AE有相关性,剂量学指标中食管受照最大剂量、平均剂量、V20、V25、V30、V35、V40、V45、V50、V55、V60的差异均有统计学意义(P〈0.001),同时放化疗和V55在Binary Logistic多因素分析中的差异有统计学意义。结论Ⅲ~Ⅳ期非小细胞肺癌三维适形放射治疗中,同时化放疗和V55是预测AE最有价值的指标。 Objective To report the incidence of acute radiation esophagitis(AE) and analyze the factors related to acute radiation esophagitis in the treatment of stage Ⅲ-Ⅳ non-small cell lung cancer with three dimensional conformal radiotherapy(3DCRT).Methods 195 non-small cell lung cancer patients treated with 3DCRT between March 2006 and November 2008 were selected.They consisted of 165 men and 30 women.Seventy-nine of them were treated with concurrent chemotherapy(CCT).The median biologic effective dose of radiotherapy was 72.0 Gy.The incidence rate of the AE was observed.The clinical and dosimetric factors associated with grade-2 or more severe AE were analyzed using univariate and multivariate logistic analysis.Results AE was observed in thirty-eight cases(19.5%) with grade-2 and twenty-five cases(12.8%) with grade-3.Univariate analysis showed that clinical factors,such as pretreatment weight loss≥5%,CCT,lymph node stage,and the use of late-course hyperfractionated radiotherapy were significantly associated with grade-2 and-3 AE.Dose volume parameters received by esophagus including maximal esophageal dose,mean esophageal dose,V20,V25,V30,V35,V40,V45,V50,V55,V60 were also associated with AE.Multivariate logistic analysis showed that CCT and V55 were statistically most significant factors of AE(P0.001).Conclusion CCT and V55 were the most valuable predictors of grade 2 or more severe AE in the 3D-CRT treatment of stage Ⅲ-Ⅳ NSCLC.
出处 《中国肿瘤临床与康复》 2011年第3期252-255,共4页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肺肿瘤 三维适形放射疗法 急性放射性食管炎 同步放化疗 Lung neoplasms 3-Dimensional conformal radiotherapy Acute radiation esophagitis Concurrent chemotherapy
  • 相关文献

参考文献4

二级参考文献30

  • 1吕纪马,王绿化,周宗玫,张红星,陈东福.放射治疗同步紫杉醇化疗局部晚期非小细胞肺癌的Ⅱ期临床研究[J].中华放射肿瘤学杂志,2004,13(2):89-92. 被引量:68
  • 2Wen-BoQiao Yan-HuiZhao Yan-BinZhao Rui-ZhiWang.Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal toxicity[J].World Journal of Gastroenterology,2005,11(17):2626-2629. 被引量:10
  • 3封巍,祝淑钗,翟福山,邱嵘,李娟,王玉祥.三维适形放疗非小细胞肺癌所致食管损伤相关因素分析[J].中华放射肿瘤学杂志,2005,14(2):94-98. 被引量:17
  • 4吴一龙,蒋国梁,廖美琳,王绿化,周清华,杨学宁,孙燕,无.局部晚期非小细胞肺癌化放疗共识[J].循证医学,2005,5(3):186-188. 被引量:36
  • 5Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage Ⅲ non-small cell lung cancer. N Engl J Med,1990, 323:940-945.
  • 6Sause W, Kolesar P, Taylor S, et al. Final results of phase Ⅲ trial in regionally advanced unresectable non-small cell lung cancer: radiation therapy oncology group, eastern cooperative oncology group, and southwest oncology group. Chest, 2000,117 : 358-364.
  • 7Curran WJ, Scott C, Langer C, et al. Phase Ⅲ comparison of sequential vs concurrent chemoradiation for patients with unresected stage Ⅲ non-small lung cancer ( NSCLC ) : initial report of radiation therapy oncology group (RTOG) 9410. Proc Amsoc Clin Oncol,2000,19 : 1891a.
  • 8Choy H, Akerley W, Graziano S. Multiinstitutional phase Ⅱ trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small cell lung cancer. J Clin Oncol, 1998, 16:3316-3322.
  • 9Bradley J, Deasy JO, Bentzen S, et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys, 2004,58:1106-1113.
  • 10Singh AK, Lockett MA, Bradley JD. Predictors of radiation-induced esophageal toxicity in patients with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys, 2003,55:337- 341.

共引文献30

同被引文献45

  • 1祝淑钗,李任,王玉祥,李娟,邱嵘.500例中晚期食管癌单纯放疗的多因素分析[J].中华放射肿瘤学杂志,2005,14(4):253-258. 被引量:68
  • 2刘阳晨,高飞,周绍兵,叶宏勋,赵莺,尹小祥.三维适形放射治疗胸部肿瘤致食管损伤的相关因素分析[J].临床肿瘤学杂志,2007,12(3):201-203. 被引量:6
  • 3李高峰,吴德华,李桂生,陈龙华.三维适形放射治疗局部晚期肺癌所致急性食管损伤相关因素分析[J].肿瘤防治研究,2007,34(7):520-523. 被引量:2
  • 4W erner- Wasik M. Treatment - related esophagitis[J]. Semin Oncol, 2005 ,32(2 Suppl 3):S60-S66.
  • 5Cooper JS,Guo MD,Herskovic A,et al.Chemoradiotherapy of locally advanced esophageal cancer-long-term follow-up of a prospective randomized trial (RTOG 85-(1).Radiation Therapy Oncology Group[J]JAMA, 1999,281(17):1623-1627.
  • 6Minsky BD .Pajak TF, Ginsberg RJ ,et aUNT 0123 (Radia-tion Therapy Oncology Group 94-05) phase ill trial of combined-modality therapy for esophageal cancer:high-dose versus standard-dose radiation therapy[J]J Clin On-col ,2002 ,20(5):1167-1174.
  • 7Movsas B, Scott C, Langer C, et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated ra-diation: radiation therapy oncology group trial 98-01[J]'] Clin Oncol,2005 ,23(10):2145-2154.
  • 8Komaki R, Seiferheld W, Ettinger D, et al.Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung can-cer: long-term follow-up of RTOG 92-04[J].Int J Radiat Oncol Biol Phys,2002,53(3):548-557.
  • 9W erner- Wasik M, Pequignot E, Leeper D, et al.Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of the irradiated esopha-gus:a multivariate analysis of patients with lung cancer treated with nonoperative therapy[J].Int J Radiat Oncol BioI Phys, 2000,48(3):689-696.
  • 10W erner- Wasik M , Yorke E, Deasy J, et al.Radiation dose-volume effects in the esophagus[J].Int J Radiat Oncol Hiol Phys , 2010 ,76(3 Suppl):S86-S93.

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部